speb/financial-data huggingface dataset:
Financial ratios for CRAV.PA — annual report dated 2023-12-31
Total revenue: 459141111.1111111
Net income: 96007777.77777778
Capital expenditures: 47712222.222222224
Operating cash flow: -955873333.3333333
Depreciation & amortization: 23351111.111111112
Net tangible assets: 4155690000
Owner earnings: 71646666.66666667
Return on net tangible assets (%): 1.7240618685866047
Buffett classification: The Gruesome
Stock price: 85.23333333333332
P/E ratio: 1.0644265999282463
Shares outstanding: 1198982
Book value: 4160951111.1111145
P/B ratio: 0.024560065652724675
Market cap (USD): 102193232.46666665
Debt to equity: 0.1166899341389895
Effective tax rate (%): 7.325418020742839
COGS to revenue (%): 0
SG&A to revenue (%): 21.67017160059725
Free cash flow (dilution-adjusted): -1003585555.5555556
Buyback yield (%): 0
Retained earnings: 96007777.77777778
Receivables turnover: 1.2770158349506162
Capitalized R&D asset: 0
FCF margin (%): -218.5788924731443
Revenue growth (%): -12.559256610449626
Rule of 40 score: -231.13814908359393
Financial ratios for CRAV.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4146089583.3333335
Buffett classification: The Gruesome
Stock price: 85.64583333333333
Shares outstanding: 1198982
Book value: 4151979166.666664
P/B ratio: 0.024732256213151373
Market cap (USD): 102687812.54166666
Debt to equity: 0.09097292957675814
Buyback yield (%): 0
Retained earnings: 89162500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRAV.PA — annual report dated 2024-12-31
Total revenue: 443116666.6666667
Net income: 89162500
Capital expenditures: 43452083.333333336
Operating cash flow: 282825000
Depreciation & amortization: 23047916.666666668
Net tangible assets: 4146089583.3333335
Owner earnings: 68758333.33333334
Return on net tangible assets (%): 1.6583899588115913
Buffett classification: The Gruesome
Stock price: 85.64583333333333
P/E ratio: 1.1516928365811485
Shares outstanding: 1198982
Book value: 4151979166.666664
P/B ratio: 0.024732256213151373
Market cap (USD): 102687812.54166666
Debt to equity: 0.09097292957675814
Effective tax rate (%): 4.793895846773297
COGS to revenue (%): 0
SG&A to revenue (%): 21.74370933162824
Free cash flow (dilution-adjusted): 239372916.6666667
Buyback yield (%): 0
Retained earnings: 89162500
Receivables turnover: 1.1412872588737155
Capitalized R&D asset: 0
FCF margin (%): 54.02029187196751
Revenue growth (%): -3.490091402546294
Rule of 40 score: 50.53020046942122
Financial ratios for CRAV.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 4871045882.3529415
Buffett classification: The Gruesome
Stock price: 113.55294117647058
Shares outstanding: 1198982
Book value: 4877674117.647057
P/B ratio: 0.027912470008005275
Market cap (USD): 136147932.51764706
Debt to equity: 0.07376008285530498
Buyback yield (%): 0
Retained earnings: 72638823.52941176
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTXR — annual report dated 2021-09-30
Capital expenditures: 6938
Buffett classification: The Gruesome
Stock price: 50.75
Shares outstanding: 27452570
Market cap (USD): 1393217927.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTXR — annual report dated 2022-09-30
Total revenue: 0
Operating income: -33316045
Net income: -33640646
Capital expenditures: 0
Operating cash flow: -28361256
Depreciation & amortization: 179677
Net tangible assets: 34079069
Owner earnings: -33460969
Return on net tangible assets (%): -98.18627674365166
Buffett classification: The Gruesome
Stock price: 30.25
Shares outstanding: 27452570
Book value: 103426245
P/B ratio: 8.029298970488584
Market cap (USD): 830440242.5
Debt to equity: 0.006557658551753475
Current ratio: 9.83756113670339
Quick ratio: 9.83756113670339
Free cash flow (dilution-adjusted): -32267210
Buyback yield (%): 0
Retained earnings: -129688467
Capitalized R&D asset: 17655482
ROCI (R&D-adjusted, %): -16.94848559230192
Rule of 40 score: 0
Financial ratios for CTXR — annual report dated 2023-09-30
Total revenue: 0
Operating income: -36732018
Net income: -32542912
Capital expenditures: 0
Operating cash flow: -29060212
Depreciation & amortization: 194316
Net tangible assets: 22084312
Owner earnings: -32348596
Return on net tangible assets (%): -146.47771685167282
Buffett classification: The Gruesome
Stock price: 17.1
Shares outstanding: 27452570
Book value: 91431488
P/B ratio: 5.134324697854639
Market cap (USD): 469438947.00000006
Debt to equity: 0.005263449283467858
Current ratio: 5.947473930164698
Quick ratio: 5.947473930164698
Free cash flow (dilution-adjusted): -35676917
Buyback yield (%): 0
Retained earnings: -162231379
Capitalized R&D asset: 26648901.94
ROCI (R&D-adjusted, %): -26.299069644865057
Rule of 40 score: 0
Financial ratios for CTXR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.52
Shares outstanding: 27452570
Market cap (USD): 343706176.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTXR — annual report dated 2024-09-30
Total revenue: 0
Operating income: -41995681
Net income: -39138839
Capital expenditures: 0
Operating cash flow: -28201375
Depreciation & amortization: 209611
Net tangible assets: -32069346
Owner earnings: -38929228
Buffett classification: The Gruesome
Stock price: 12.52
Shares outstanding: 27452570
Book value: 74101830
P/B ratio: 4.638295388926292
Market cap (USD): 343706176.4
Debt to equity: 0.0035473482908586736
Current ratio: 0.397060567386061
Quick ratio: 0.16618491521508577
Free cash flow (dilution-adjusted): -40041053
Buyback yield (%): 0
Retained earnings: -201370218
Inventory turnover: 0
Capitalized R&D asset: 27662128.490000002
ROCI (R&D-adjusted, %): -41.36718835341428
Rule of 40 score: 0
Financial ratios for CTXR — quarterly report dated 2024-12-31
Gross profit: 0
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 4
Shares outstanding: 27452570
Market cap (USD): 109810280
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTXR — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: 0
Operating income: -11260678
Net income: -10916505
Capital expenditures: 0
Operating cash flow: -4539476
Depreciation & amortization: 56010
Net tangible assets: -41487384
Owner earnings: -10860495
Buffett classification: The Gruesome
Stock price: 1.49
Shares outstanding: 27452570
Book value: 63575792
P/B ratio: 0.6433947264078125
Market cap (USD): 40904329.3
Debt to equity: 0.014656443446272758
Current ratio: 0.3683979767523243
Quick ratio: 0.06085415694184063
Free cash flow (dilution-adjusted): -7241507
Buyback yield (%): 0
Retained earnings: -222054969
Inventory turnover: 0
Capitalized R&D asset: 3766525
ROCI (R&D-adjusted, %): -11.608745012833843
Rule of 40 score: 0
Financial ratios for CTXR — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -8788007
Net income: -8789872
Capital expenditures: 0
Operating cash flow: -5406620
Depreciation & amortization: 41367
Net tangible assets: -37088246
Owner earnings: -8748505
Buffett classification: The Gruesome
Stock price: 1.59
Shares outstanding: 27452570
Book value: 67560930
P/B ratio: 0.6460773452940924
Market cap (USD): 43649586.300000004
Debt to equity: 0.027851170787613493
Current ratio: 0.4747319629094704
Quick ratio: 0.14278456582261967
Interest coverage ratio: -51.01535451811775
Free cash flow (dilution-adjusted): -8126294
Buyback yield (%): 0
Retained earnings: -230844841
Inventory turnover: 0
Capitalized R&D asset: 4144896.75
ROCI (R&D-adjusted, %): -11.206189076133336
Rule of 40 score: 0
Financial ratios for CTXR — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -8437309
Net income: -7959288
Capital expenditures: 0
Operating cash flow: -11880790
Depreciation & amortization: 62038
Net tangible assets: -34596618
Owner earnings: -7897250
Buffett classification: The Gruesome
Stock price: 1.24
Shares outstanding: 27452570
Book value: 77527600
P/B ratio: 0.4390847491731977
Market cap (USD): 34041186.8
Debt to equity: 0.023388741557845205
Current ratio: 0.621944444073371
Quick ratio: 0.125744466070604
Interest coverage ratio: -88.33028685092127
Free cash flow (dilution-adjusted): -14770552
Buyback yield (%): 0
Retained earnings: -238804129
Inventory turnover: 0
Capitalized R&D asset: 3970827
ROCI (R&D-adjusted, %): -10.15496250836203
Rule of 40 score: 0
Financial ratios for CTXR — annual report dated 2025-09-30
Total revenue: 0
Operating income: -38525608
Net income: -37433911
Capital expenditures: 0
Operating cash flow: -26552738
Depreciation & amortization: 214250
Net tangible assets: -34596618
Owner earnings: -37219661
Buffett classification: The Gruesome
Stock price: 1.24
Shares outstanding: 27452570
Book value: 77527600
P/B ratio: 0.4390847491731977
Market cap (USD): 34041186.8
Debt to equity: 0.023388741557845205
Current ratio: 0.621944444073371
Quick ratio: 0.125744466070604
Interest coverage ratio: -143.86929666669155
Free cash flow (dilution-adjusted): -37389029
Buyback yield (%): 0
Retained earnings: -238804129
Inventory turnover: 0
Capitalized R&D asset: 22024407.240000002
ROCI (R&D-adjusted, %): -38.25169035064867
Rule of 40 score: 0
Financial ratios for CTXR — quarterly report dated 2025-12-31
Total revenue: 3944111
Gross profit: 3154903
Operating income: -9019208
Net income: -8220785
Capital expenditures: 0
Operating cash flow: -13008822
Depreciation & amortization: 573438
Net tangible assets: -21615196
Owner earnings: -7647347
Buffett classification: The Gruesome
Stock price: 0.78
Shares outstanding: 27452570
Book value: 93467970
P/B ratio: 0.22909457218339074
Market cap (USD): 21413004.6
Debt to equity: 0.019575112201538132
Current ratio: 0.9931429796331155
Quick ratio: 0.4006004901704185
Interest coverage ratio: -57.987167123146754
COGS to revenue (%): 34.966789727773886
R&D to revenue (%): 40.55968505957363
SG&A to revenue (%): 253.5667479946685
Free cash flow (dilution-adjusted): -17289049
Buyback yield (%): 0
Retained earnings: -247024914
Inventory turnover: 0.06091736235090225
Receivables turnover: 0.9740683819238346
Capitalized R&D asset: 3234618.87
ROCI (R&D-adjusted, %): -8.575632513699173
FCF margin (%): -438.35097440208955
Rule of 40 score: -438.35097440208955
Financial ratios for DBO.AX — annual report dated 2022-06-30
Operating income: -560108.275862069
Net income: -556049.6551724138
Capital expenditures: 989275.1724137932
Net tangible assets: 9375044.137931034
Owner earnings: -1545324.827586207
Return on net tangible assets (%): -16.48338722304131
Buffett classification: The Gruesome
Stock price: 0.034482758620689655
Shares outstanding: 505072975
Book value: 9375044.137931034
P/B ratio: 1.8577309318782795
Market cap (USD): 17416309.48275862
Debt to equity: 0
Current ratio: 66.12515531809144
Quick ratio: 66.12515531809144
Free cash flow (dilution-adjusted): -1225442.0689655172
Buyback yield (%): 0.9791693962639757
Retained earnings: -623802.7586206896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.974460147829006
Rule of 40 score: 0
Financial ratios for DBO.AX — annual report dated 2023-06-30
Operating income: -2783032.450331126
Net income: -2748931.7880794704
Capital expenditures: 654710.5960264901
Net tangible assets: 6363476.158940397
Owner earnings: -3403642.3841059604
Return on net tangible assets (%): -53.48715543349677
Buffett classification: The Gruesome
Stock price: 0.039735099337748346
Shares outstanding: 505072975
Book value: 6295135.761589404
P/B ratio: 3.188036858059755
Market cap (USD): 20069124.834437087
Debt to equity: 0
Current ratio: 5.710822634743846
Quick ratio: 5.710822634743846
Free cash flow (dilution-adjusted): -913043.0463576159
Buyback yield (%): 0
Retained earnings: -3347947.682119205
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -44.20925228193112
Rule of 40 score: 0
Financial ratios for DBO.AX — annual report dated 2024-06-30
Operating income: -6508842.666666667
Net income: -6511964.666666667
Capital expenditures: 1622716
Net tangible assets: 471238.6666666667
Owner earnings: -8134680.666666667
Return on net tangible assets (%): -1726.233698989047
Buffett classification: The Gruesome
Stock price: 0.013333333333333334
Shares outstanding: 505072975
Book value: 471238.6666666666
P/B ratio: 14.290648899779026
Market cap (USD): 6734306.333333334
Debt to equity: 0
Current ratio: 7.159016450578558
Quick ratio: 7.159016450578558
Free cash flow (dilution-adjusted): -1950184.6666666667
Buyback yield (%): 0.41111880911862286
Retained earnings: -9882232
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1381.2199904365518
Rule of 40 score: 0
Financial ratios for DNP — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.55
Shares outstanding: 376821218
Market cap (USD): 2845000195.9
Buyback yield (%): 3.268892569287854
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DNP — annual report dated 2022-10-31
Total revenue: -12821017
Net income: -21806565
Capital expenditures: 0
Operating cash flow: 182224827
Net tangible assets: 3066910699
Owner earnings: -21806565
Return on net tangible assets (%): -0.711027060784987
Buffett classification: The Gruesome
Stock price: 7.96
Shares outstanding: 376821218
Book value: 3066910699
P/B ratio: 0.9780189870732197
Market cap (USD): 2999496895.28
Debt to equity: 0.29246933250859547
Free cash flow (dilution-adjusted): 182224827
Buyback yield (%): 0
Retained earnings: 609998890
Receivables turnover: -0.8191379531647427
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DNP — annual report dated 2023-10-31
Total revenue: -176871187
Net income: -185918215
Capital expenditures: 0
Operating cash flow: 174153385
Net tangible assets: 2684320213
Owner earnings: -185918215
Return on net tangible assets (%): -6.926081847449099
Buffett classification: The Gruesome
Stock price: 7.25
Shares outstanding: 376821218
Book value: 2684320213
P/B ratio: 1.017745132368826
Market cap (USD): 2731953830.5
Debt to equity: 0.36223081296001847
Free cash flow (dilution-adjusted): 174153385
Buyback yield (%): 2.7452879753196107
Retained earnings: 223410948
Receivables turnover: -10.29179800932697
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DNP — annual report dated 2024-10-31
Total revenue: 851710639
Net income: 843070092
Capital expenditures: 0
Operating cash flow: 205449202
Net tangible assets: 3300437018
Owner earnings: 843070092
Return on net tangible assets (%): 25.54419573535398
Buffett classification: The Gruesome
Stock price: 8.37
P/E ratio: 3.741081108900255
Shares outstanding: 376821218
Book value: 3300437018
P/B ratio: 0.9556290810758321
Market cap (USD): 3153993594.66
Debt to equity: 0.2946837705721067
COGS to revenue (%): 0
SG&A to revenue (%): 0.9837580530680679
Free cash flow (dilution-adjusted): 205449202
Buyback yield (%): 0
Retained earnings: 844828495
Receivables turnover: 25.559421250942336
Capitalized R&D asset: 0
FCF margin (%): 24.12194853421339
Rule of 40 score: 24.12194853421339
Financial ratios for DNP — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 3300437018
Buffett classification: The Gruesome
Stock price: 8.37
Shares outstanding: 376821218
Book value: 3300437018
P/B ratio: 0.9556290810758321
Market cap (USD): 3153993594.66
Debt to equity: 0.2946837705721067
Buyback yield (%): 0
Retained earnings: 844828495
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DNP — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 3457122000
Buffett classification: The Gruesome
Stock price: 8.78
Shares outstanding: 376821218
Book value: 3457122000
P/B ratio: 0.9570070984015027
Market cap (USD): 3308490294.04
Debt to equity: 0.28136264789035503
Buyback yield (%): 0
Retained earnings: 972783000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EBK.DE — annual report dated 2021-12-31
Total revenue: 36531704545.454544
Gross profit: 7356704545.454545
Operating income: 687272727.2727273
Net income: 501363636.3636364
Capital expenditures: 2683977272.7272725
Operating cash flow: 8633863636.363636
Depreciation & amortization: 3006704545.4545455
Net tangible assets: 1398181818.1818182
Owner earnings: 824090909.0909095
Return on net tangible assets (%): 58.94018205461641
Capex to operating income (%): 390.5257936507936
Buffett classification: The Gruesome
Stock price: 76.75
P/E ratio: 49.66167305448776
Shares outstanding: 324411166
Book value: 9658295454.54544
P/B ratio: 2.5779452603908593
Market cap (USD): 24898556990.5
Debt to equity: 1.3357217653218518
Current ratio: 1.0525013944496524
Quick ratio: 0.9862248816542993
Effective tax rate (%): 14.046366647184886
Interest coverage ratio: 1.8227848101265822
COGS to revenue (%): 79.86213718469946
SG&A to revenue (%): 2.5040515865733064
Free cash flow (dilution-adjusted): 5949886363.636364
Buyback yield (%): 0
Retained earnings: 6525113636.363636
Inventory turnover: 11.312623925974885
Receivables turnover: 5.400739185216296
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6332570894645737
FCF margin (%): 16.28691143122879
Rule of 40 score: 16.28691143122879
Financial ratios for EBK.DE — annual report dated 2022-12-31
Total revenue: 59577234042.55319
Gross profit: 5544042553.191489
Operating income: 271595744.6808511
Net income: 1961595744.6808512
Capital expenditures: 2947553191.489362
Operating cash flow: 1920000000
Depreciation & amortization: 2481808510.638298
Net tangible assets: 6111489361.702128
Owner earnings: 1495851063.8297873
Return on net tangible assets (%): 24.476047904191613
Capex to operating income (%): 1085.2722287504894
Buffett classification: The Gruesome
Stock price: 83.2127659574468
P/E ratio: 13.761831663604315
Shares outstanding: 324411166
Book value: 13584361702.127663
P/B ratio: 1.9872225889062043
Market cap (USD): 26995150430.340424
Debt to equity: 0.984071170698472
Current ratio: 1.1342802032793975
Quick ratio: 1.0014196073233599
Effective tax rate (%): 23.023294648075478
Interest coverage ratio: 0.6281988188976378
COGS to revenue (%): 90.69436061897126
SG&A to revenue (%): 1.8824126022720373
Free cash flow (dilution-adjusted): -1027553191.4893618
Buyback yield (%): 0
Retained earnings: 7736914893.617022
Inventory turnover: 13.33417342679373
Receivables turnover: 10.01602489582029
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6252173444548389
FCF margin (%): -1.724741351294404
Revenue growth (%): 63.08364141187079
Rule of 40 score: 61.35890006057639
Financial ratios for EBK.DE — annual report dated 2023-12-31
Total revenue: 49367444444.44444
Gross profit: 10229777777.777777
Operating income: 2692111111.111111
Net income: 2036222222.222222
Capital expenditures: 4893111111.111111
Operating cash flow: 999666666.6666666
Depreciation & amortization: 2663333333.3333335
Net tangible assets: 6825000000
Owner earnings: -193555555.55555534
Return on net tangible assets (%): -2.8359788359788327
Capex to operating income (%): 181.75739815923066
Buffett classification: The Gruesome
Stock price: 80.1111111111111
P/E ratio: 12.763311725744842
Shares outstanding: 324411166
Book value: 17614444444.444443
P/B ratio: 1.4754333607897558
Market cap (USD): 25988938965.111107
Debt to equity: 1.0205765470257997
Current ratio: 1.3885651014697133
Quick ratio: 1.2362889187581252
Effective tax rate (%): 35.49000281610814
Interest coverage ratio: 2.863609502422882
COGS to revenue (%): 79.27829181174278
SG&A to revenue (%): 3.546196661317512
Free cash flow (dilution-adjusted): -3893444444.444444
Buyback yield (%): 0
Retained earnings: 9510555555.555555
Inventory turnover: 12.742430271678183
Receivables turnover: 9.710354926129906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.203186036073762
FCF margin (%): -7.886663950826793
Revenue growth (%): -17.137065461643253
Rule of 40 score: -25.023729412470047
Financial ratios for EBK.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 69.82222222222222
Shares outstanding: 324411166
Market cap (USD): 22651108523.822224
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EBK.DE — annual report dated 2024-12-31
Total revenue: 35962916666.66667
Gross profit: 9362187500
Operating income: 2722291666.666667
Net income: 1900729166.6666667
Capital expenditures: 5711979166.666667
Operating cash flow: 2729375000
Depreciation & amortization: 2407500000
Net tangible assets: 7386145833.333334
Owner earnings: -1403750000
Return on net tangible assets (%): -19.005175793645197
Capex to operating income (%): 209.82245350883906
Buffett classification: The Gruesome
Stock price: 58.10416666666667
P/E ratio: 9.917057510538719
Shares outstanding: 324411166
Book value: 18508125000
P/B ratio: 1.018452191012956
Market cap (USD): 18849640457.791668
Debt to equity: 1.090697779128536
Current ratio: 1.538516073129337
Quick ratio: 1.3250932735618683
Effective tax rate (%): 32.22271748012778
Interest coverage ratio: 2.6580553295362086
COGS to revenue (%): 73.96710732119891
SG&A to revenue (%): 3.965890790281655
Free cash flow (dilution-adjusted): -2982604166.666667
Buyback yield (%): 0
Retained earnings: 9792187500
Inventory turnover: 8.56849981545482
Receivables turnover: 7.494876693296283
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.1942424880846865
FCF margin (%): -8.293554703340247
Revenue growth (%): -27.152565680936817
Rule of 40 score: -35.446120384277066
Financial ratios for EBK.DE — quarterly report dated 2024-12-31
Total revenue: 8075729166.666667
Gross profit: 2027708333.3333335
Operating income: -474062500
Net income: -247187500
Capital expenditures: 2334062500
Operating cash flow: 732291666.6666667
Depreciation & amortization: 1108645833.3333335
Net tangible assets: 7386145833.333334
Owner earnings: -1472604166.6666665
Return on net tangible assets (%): -19.93738276897908
Buffett classification: The Gruesome
Stock price: 58.10416666666667
Shares outstanding: 324411166
Book value: 18508125000
P/B ratio: 1.018452191012956
Market cap (USD): 18849640457.791668
Debt to equity: 1.090697779128536
Current ratio: 1.538516073129337
Quick ratio: 1.3250932735618683
Interest coverage ratio: -9.48125
COGS to revenue (%): 74.89132818243968
Free cash flow (dilution-adjusted): -1601770833.3333335
Buyback yield (%): 0
Retained earnings: 9792187500
Inventory turnover: 1.9481595812502097
Receivables turnover: 1.683027961097603
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.9045304034312927
FCF margin (%): -19.834380280418436
Rule of 40 score: -19.834380280418436
Financial ratios for EBK.DE — quarterly report dated 2025-03-31
Total revenue: 10819130434.782608
Gross profit: 2671413043.4782605
Operating income: 1194239130.4347825
Net income: 825869565.2173913
Capital expenditures: 1174782608.695652
Operating cash flow: 2317282608.695652
Depreciation & amortization: 597065217.3913044
Net tangible assets: 8385652173.913043
Owner earnings: 248152173.9130435
Return on net tangible assets (%): 2.959247161300358
Capex to operating income (%): 98.37080185673977
Buffett classification: The Gruesome
Stock price: 72.75
P/E ratio: 7.144261430764676
Shares outstanding: 324411166
Book value: 20153260869.565216
P/B ratio: 1.1710716434054258
Market cap (USD): 23600912326.5
Debt to equity: 0
Current ratio: 1.5260232588833975
Quick ratio: 1.379936646673217
Effective tax rate (%): 24.420570973838654
Interest coverage ratio: 3.1080622347949083
COGS to revenue (%): 75.30843112039864
Free cash flow (dilution-adjusted): 1142500000
Buyback yield (%): 0
Inventory turnover: 3.7624353761983635
Receivables turnover: 1.8888720206467284
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.166343302416556
FCF margin (%): 10.559998392541392
Revenue growth (%): 33.97094196075307
Rule of 40 score: 44.53094035329447
Financial ratios for EBK.DE — quarterly report dated 2025-06-30
Total revenue: 8876000000
Gross profit: 2080235294.1176472
Operating income: 289294117.64705884
Net income: 99176470.5882353
Capital expenditures: 1802941176.4705882
Operating cash flow: 435176470.5882353
Depreciation & amortization: 596000000
Net tangible assets: 8382705882.3529415
Owner earnings: -1107764705.8823528
Return on net tangible assets (%): -13.214882180399421
Capex to operating income (%): 623.220821472143
Buffett classification: The Gruesome
Stock price: 80.5764705882353
P/E ratio: 38.5624808052718
Shares outstanding: 324411166
Book value: 20920941176.470596
P/B ratio: 1.2494613198900058
Market cap (USD): 26139906775.69412
Debt to equity: 0
Current ratio: 1.3387867433484373
Quick ratio: 1.1728534913442548
Effective tax rate (%): 43.15576534052596
Interest coverage ratio: 0.70438269836723
COGS to revenue (%): 76.56336982742624
Free cash flow (dilution-adjusted): -1367764705.882353
Buyback yield (%): 0
Retained earnings: 11088352941.176472
Inventory turnover: 2.5278543608594806
Receivables turnover: 1.4757452468507941
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5004273678212381
FCF margin (%): -15.409697001829123
Revenue growth (%): -17.960135026523062
Rule of 40 score: -33.369832028352185
Financial ratios for EBK.DE — quarterly report dated 2025-09-30
Total revenue: 9802235294.117647
Gross profit: 2422470588.2352943
Operating income: 604823529.4117647
Net income: 310000000
Capital expenditures: 1813176470.5882354
Operating cash flow: 1044823529.4117647
Depreciation & amortization: 831176470.5882353
Net tangible assets: 12392117647.058825
Owner earnings: -672000000
Return on net tangible assets (%): -5.422801970892312
Capex to operating income (%): 299.7860338455554
Buffett classification: The Gruesome
Stock price: 75.75294117647059
P/E ratio: 24.877144939529774
Shares outstanding: 324411166
Book value: 25441411764.70588
P/B ratio: 0.9659487532480625
Market cap (USD): 24575099974.988235
Debt to equity: 0
Current ratio: 1.6514998638671343
Quick ratio: 1.4429042745719822
Effective tax rate (%): 30.03186404673393
Interest coverage ratio: 1.803859649122807
COGS to revenue (%): 75.28654928647727
Free cash flow (dilution-adjusted): -768352941.1764706
Buyback yield (%): 0
Retained earnings: 11276235294.117647
Inventory turnover: 2.408077085492725
Receivables turnover: 1.9758353292703168
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9469219051899279
FCF margin (%): -7.838548230295611
Revenue growth (%): 10.435278212231266
Rule of 40 score: 2.5967299819356544
Financial ratios for ERNA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31275
Shares outstanding: 1166333
Market cap (USD): 36477064575
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ERNA — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 0
Operating income: -26947000
Net income: -24579000
Capital expenditures: 47000
Operating cash flow: -20976000
Depreciation & amortization: 497000
Net tangible assets: 10063000
Owner earnings: -24129000
Return on net tangible assets (%): -239.77938984398293
Buffett classification: The Gruesome
Stock price: 1207.5
Shares outstanding: 1166333
Book value: 12107000
P/B ratio: 116.32502663748245
Market cap (USD): 1408347097.5
Debt to equity: 0.09961179482943752
Current ratio: 1.7874314084139011
Quick ratio: 1.7874314084139011
Interest coverage ratio: -898.2333333333333
Free cash flow (dilution-adjusted): -24208000
Buyback yield (%): 0
Retained earnings: -165297000
Receivables turnover: 0
Capitalized R&D asset: 10392000
ROCI (R&D-adjusted, %): -80.02158532198105
Rule of 40 score: 0
Financial ratios for ERNA — annual report dated 2023-12-31
Total revenue: 68000
Gross profit: -168000
Operating income: -20675000
Net income: -21668000
Capital expenditures: 19000
Operating cash flow: -20408000
Depreciation & amortization: 1123000
Net tangible assets: 189000
Owner earnings: -20564000
Return on net tangible assets (%): -10880.423280423282
Buffett classification: The Gruesome
Stock price: 675
Shares outstanding: 1166333
Book value: 2233000
P/B ratio: 352.5637147335423
Market cap (USD): 787274775
Debt to equity: 18.7384684281236
Current ratio: 1.4603681728282367
Quick ratio: 1.4603681728282367
Interest coverage ratio: -33.67263843648208
COGS to revenue (%): 347.05882352941177
R&D to revenue (%): 8705.882352941177
SG&A to revenue (%): 21451.470588235294
Free cash flow (dilution-adjusted): -21669000
Buyback yield (%): 0
Retained earnings: -186981000
Receivables turnover: 0.16
Capitalized R&D asset: 12882640
ROCI (R&D-adjusted, %): -36.420880286610085
Rosenberg metric: -0.016166281755196306
FCF margin (%): -31866.176470588238
Rule of 40 score: -31866.176470588238
Financial ratios for ERNA — quarterly report dated 2024-09-30
Capital expenditures: 19000
Buffett classification: The Gruesome
Stock price: 393.75
Shares outstanding: 1166333
Market cap (USD): 459243618.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ERNA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 108.75
Shares outstanding: 1166333
Market cap (USD): 126838713.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ERNA — annual report dated 2024-12-31
Total revenue: 32637.95
Gross profit: -63362.05
Operating income: -17799362.05
Net income: -44539000
Capital expenditures: 365000
Operating cash flow: -15836000
Depreciation & amortization: 1638000
Net tangible assets: -343000
Owner earnings: -43266000
Buffett classification: The Gruesome
Stock price: 108.75
Shares outstanding: 1166333
Book value: 1701000
P/B ratio: 74.5671450617284
Market cap (USD): 126838713.75
Debt to equity: 0.4021164021164021
Current ratio: 0.8005445881552076
Quick ratio: 0.8005445881552076
Interest coverage ratio: -2.6361614410545027
COGS to revenue (%): 294.13612068159915
R&D to revenue (%): 14106.278121021694
SG&A to revenue (%): 40235.37017490376
Free cash flow (dilution-adjusted): -17725000
Buyback yield (%): 0
Retained earnings: -231536000
Receivables turnover: 0.07468638443935927
Capitalized R&D asset: 11999760
ROCI (R&D-adjusted, %): -140.72779147791186
Rosenberg metric: 0.01767532939189189
FCF margin (%): -54307.94519876401
Revenue growth (%): -52.00301470588236
Rule of 40 score: -54359.94821346989
Financial ratios for ERNA — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: 0
Operating income: -2730000
Net income: -8202000
Capital expenditures: 0
Operating cash flow: -2065000
Depreciation & amortization: 69000
Net tangible assets: -7994000
Owner earnings: -8133000
Buffett classification: The Gruesome
Stock price: 67.5
Shares outstanding: 1166333
Book value: -5950000
Market cap (USD): 78727477.5
Debt to equity: -0.48436974789915965
Current ratio: 0.2118221881586511
Quick ratio: 0.2118221881586511
Free cash flow (dilution-adjusted): -2567000
Buyback yield (%): 0
Retained earnings: -239738000
Receivables turnover: 0
Capitalized R&D asset: 1309000
Rule of 40 score: 0
Financial ratios for ERNA — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: 0
Operating income: -2501000
Net income: -3139000
Capital expenditures: 0
Operating cash flow: -2532000
Depreciation & amortization: 55000
Net tangible assets: 2400000
Owner earnings: -3084000
Return on net tangible assets (%): -128.5
Buffett classification: The Gruesome
Stock price: 46
Shares outstanding: 1166333
Book value: 4444000
P/B ratio: 12.072753825382538
Market cap (USD): 53651318
Debt to equity: 0.13343834383438344
Current ratio: 1.8076197661259903
Quick ratio: 1.8076197661259903
Free cash flow (dilution-adjusted): -2900000
Buyback yield (%): 0
Retained earnings: -242885000
Receivables turnover: 0
Capitalized R&D asset: 2013030
ROCI (R&D-adjusted, %): -31.384834214652113
Rosenberg metric: 0
Rule of 40 score: 0
Financial ratios for ERNA — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: 0
Operating income: -1993000
Net income: -1240000
Capital expenditures: 22000
Operating cash flow: -1272000
Depreciation & amortization: 70000
Net tangible assets: 1526000
Owner earnings: -1192000
Return on net tangible assets (%): -78.1127129750983
Buffett classification: The Gruesome
Stock price: 27.5
Shares outstanding: 1166333
Book value: 3570000
P/B ratio: 8.984357843137255
Market cap (USD): 32074157.5
Debt to equity: 0.1546218487394958
Current ratio: 1.576026119402985
Quick ratio: 1.576026119402985
Free cash flow (dilution-adjusted): -1587000
Buyback yield (%): 0
Retained earnings: -244126000
Receivables turnover: 0
Capitalized R&D asset: 2228090
ROCI (R&D-adjusted, %): -33.8550116766223
Rosenberg metric: 0
Rule of 40 score: 0
Financial ratios for ERNA — annual report dated 2025-12-31
Total revenue: 0
Gross profit: 0
Operating income: -9319000
Net income: -14084000
Capital expenditures: 37000
Operating cash flow: -7017000
Depreciation & amortization: 263000
Net tangible assets: 357000
Owner earnings: -13858000
Return on net tangible assets (%): -3881.7927170868343
Buffett classification: The Gruesome
Stock price: 30
Shares outstanding: 1166333
Book value: 2401000
P/B ratio: 14.573090379008748
Market cap (USD): 34989990
Debt to equity: 0.20408163265306123
Current ratio: 1.0064246707356248
Quick ratio: 1.0064246707356248
Interest coverage ratio: -345.14814814814815
Free cash flow (dilution-adjusted): -8550000
Buyback yield (%): 0
Retained earnings: -245636000
Receivables turnover: 0
Capitalized R&D asset: 9194280
ROCI (R&D-adjusted, %): -84.39863212054884
Rosenberg metric: 0.013762391398783666
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for ERNA — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: 0
Operating income: -2094000
Net income: -1502000
Capital expenditures: 15000
Operating cash flow: -1148000
Depreciation & amortization: 69000
Net tangible assets: 357000
Owner earnings: -1448000
Return on net tangible assets (%): -405.6022408963585
Buffett classification: The Gruesome
Stock price: 30
Shares outstanding: 1166333
Book value: 2401000
P/B ratio: 14.573090379008748
Market cap (USD): 34989990
Debt to equity: 0.20408163265306123
Current ratio: 1.0064246707356248
Quick ratio: 1.0064246707356248
Free cash flow (dilution-adjusted): -1496000
Buyback yield (%): 0
Retained earnings: -245636000
Receivables turnover: 0
Capitalized R&D asset: 1744330
ROCI (R&D-adjusted, %): -53.00840027500767
Rosenberg metric: 0
Rule of 40 score: 0
Financial ratios for EVLV — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.46
Shares outstanding: 179871410
Market cap (USD): 802226488.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EVLV — annual report dated 2022-12-31
Total revenue: 52719000
Gross profit: 1400000
Operating income: -101789000
Net income: -86795000
Capital expenditures: 21149000
Operating cash flow: -74740000
Depreciation & amortization: 5443000
Net tangible assets: 226985000
Owner earnings: -102501000
Return on net tangible assets (%): -45.15760953366962
Buffett classification: The Gruesome
Stock price: 2.59
Shares outstanding: 179871410
Book value: 226985000
P/B ratio: 2.052412943146023
Market cap (USD): 465866951.9
Debt to equity: 0.13960834416371126
Current ratio: 4.948482900923452
Quick ratio: 4.775005919561615
Interest coverage ratio: -142.9620786516854
COGS to revenue (%): 97.34441093343956
R&D to revenue (%): 35.16189609059352
SG&A to revenue (%): 160.57208975891044
Free cash flow (dilution-adjusted): -121441000
Buyback yield (%): 0
Retained earnings: -192210000
Inventory turnover: 5.00331480939846
Receivables turnover: 1.5161336707695847
Capitalized R&D asset: 18537000
ROCI (R&D-adjusted, %): -29.080793168707686
FCF margin (%): -230.35527988011913
Rule of 40 score: -230.35527988011913
Financial ratios for EVLV — annual report dated 2023-12-31
Total revenue: 79565000
Gross profit: 31907000
Operating income: -89734000
Net income: -108048000
Capital expenditures: 68864000
Operating cash flow: -9801000
Depreciation & amortization: 9702000
Net tangible assets: 144140000
Owner earnings: -167210000
Return on net tangible assets (%): -116.00527265158873
Buffett classification: The Gruesome
Stock price: 4.72
Shares outstanding: 179871410
Book value: 144140000
P/B ratio: 5.890058659636464
Market cap (USD): 848993055.1999999
Debt to equity: 0.009650339947273484
Current ratio: 2.132272268824875
Quick ratio: 2.005042926373275
Interest coverage ratio: -137.20795107033638
COGS to revenue (%): 59.89819644315968
R&D to revenue (%): 30.758499340162132
SG&A to revenue (%): 122.12404951926099
Free cash flow (dilution-adjusted): -106599000
Buyback yield (%): 0
Retained earnings: -300647000
Inventory turnover: 4.607308584686775
Receivables turnover: 3.4677911436541144
Capitalized R&D asset: 36892790
ROCI (R&D-adjusted, %): -31.496412159359053
Rosenberg metric: 1.6457355559151967
FCF margin (%): -133.97725130396532
Revenue growth (%): 50.92281720062976
Rule of 40 score: -83.05443410333555
Financial ratios for EVLV — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.05
Shares outstanding: 179871410
Market cap (USD): 728479210.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EVLV — annual report dated 2024-12-31
Total revenue: 103865000
Gross profit: 59462000
Operating income: -81223000
Net income: -54017000
Capital expenditures: 31189000
Operating cash flow: -30853000
Depreciation & amortization: 17375000
Net tangible assets: 117651000
Owner earnings: -67831000
Return on net tangible assets (%): -57.654418576977676
Buffett classification: The Gruesome
Stock price: 3.95
Shares outstanding: 179871410
Book value: 117651000
P/B ratio: 6.038980284910456
Market cap (USD): 710492069.5
Debt to equity: 0.12349236300583931
Current ratio: 1.2557879825042138
Quick ratio: 1.0803854863559752
COGS to revenue (%): 42.75068598661724
R&D to revenue (%): 22.57353295142733
SG&A to revenue (%): 112.87632985124922
Free cash flow (dilution-adjusted): -92923000
Buyback yield (%): 0
Retained earnings: -354664000
Inventory turnover: 2.617638389435831
Receivables turnover: 3.558117227912713
Capitalized R&D asset: 45960120
ROCI (R&D-adjusted, %): -36.78107581920253
Rosenberg metric: 1.125934703550852
FCF margin (%): -89.46517113560873
Revenue growth (%): 30.541067052095773
Rule of 40 score: -58.92410408351296
Financial ratios for EVLV — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.95
Shares outstanding: 179871410
Market cap (USD): 710492069.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EVLV — quarterly report dated 2025-03-31
Total revenue: 32007000
Gross profit: 19150000
Operating income: -5448000
Net income: -1689000
Capital expenditures: 12730000
Operating cash flow: -2539000
Depreciation & amortization: 5530000
Net tangible assets: 121061000
Owner earnings: -8889000
Return on net tangible assets (%): -7.3425793608181
Buffett classification: The Gruesome
Stock price: 3.12
Shares outstanding: 179871410
Book value: 121061000
P/B ratio: 4.635669614491868
Market cap (USD): 561198799.2
Debt to equity: 0.11894003849299113
Current ratio: 1.0992711709993856
Quick ratio: 0.9927434903281849
Interest coverage ratio: -5448
COGS to revenue (%): 40.16933795732184
R&D to revenue (%): 15.190427094073172
SG&A to revenue (%): 61.66151154434968
Free cash flow (dilution-adjusted): -21704000
Buyback yield (%): 0
Retained earnings: -356353000
Inventory turnover: 1.2785401750198886
Receivables turnover: 0.904663651780667
Capitalized R&D asset: 4862000
ROCI (R&D-adjusted, %): -1.325755300017223
FCF margin (%): -67.81016652607242
Rule of 40 score: -67.81016652607242
Financial ratios for EVLV — quarterly report dated 2025-06-30
Total revenue: 32544000
Gross profit: 16218000
Operating income: -9427000
Net income: -40535000
Capital expenditures: 2569000
Operating cash flow: 2113000
Depreciation & amortization: 5788000
Net tangible assets: 92650000
Owner earnings: -37316000
Return on net tangible assets (%): -40.276308688613064
Buffett classification: The Gruesome
Stock price: 6.24
Shares outstanding: 179871410
Book value: 92650000
P/B ratio: 12.114383145169995
Market cap (USD): 1122397598.4
Debt to equity: 0.15397733405288722
Current ratio: 0.9313723431802753
Quick ratio: 0.8463961032144282
COGS to revenue (%): 50.165929203539825
R&D to revenue (%): 14.555678466076696
SG&A to revenue (%): 64.24532940019667
Free cash flow (dilution-adjusted): -7559000
Buyback yield (%): 0
Retained earnings: -396888000
Inventory turnover: 1.3445890298138692
Receivables turnover: 0.7630659569978194
Capitalized R&D asset: 7994540
ROCI (R&D-adjusted, %): -5.421350652703682
Rosenberg metric: -0.6030440148087207
FCF margin (%): -23.227015732546704
Revenue growth (%): 1.6777579904395914
Rule of 40 score: -21.549257742107113
Financial ratios for EVLV — quarterly report dated 2025-09-30
Total revenue: 42850000
Gross profit: 21306000
Operating income: -6289000
Net income: -1796000
Capital expenditures: 13810000
Operating cash flow: 3524000
Depreciation & amortization: 6541000
Net tangible assets: 102236000
Owner earnings: -9065000
Return on net tangible assets (%): -8.866739700301265
Buffett classification: The Gruesome
Stock price: 7.55
Shares outstanding: 179871410
Book value: 102236000
P/B ratio: 13.283277372941038
Market cap (USD): 1358029145.5
Debt to equity: 0.41472671074768186
Current ratio: 1.2705891224748003
Quick ratio: 1.1971059180373198
Interest coverage ratio: -8.820476858345021
COGS to revenue (%): 50.277712952158694
R&D to revenue (%): 13.087514585764293
SG&A to revenue (%): 51.311551925320884
Free cash flow (dilution-adjusted): -16875000
Buyback yield (%): 0
Retained earnings: -398684000
Inventory turnover: 2.4565564424173316
Receivables turnover: 0.8553747879029844
Capitalized R&D asset: 10386250
ROCI (R&D-adjusted, %): -2.943762614982728
Rosenberg metric: 1.0740975300823306
FCF margin (%): -39.38156359393232
Revenue growth (%): 31.667895771878072
Rule of 40 score: -7.713667822054248
Financial ratios for EVLV — annual report dated 2025-12-31
Total revenue: 145905000
Gross profit: 75302000
Operating income: -45801000
Net income: -33138000
Capital expenditures: 31367000
Operating cash flow: 18669000
Depreciation & amortization: 24340000
Net tangible assets: 119422000
Owner earnings: -40165000
Return on net tangible assets (%): -33.63283147158815
Buffett classification: The Gruesome
Stock price: 7.16
Shares outstanding: 179871410
Book value: 119422000
P/B ratio: 10.784271705380919
Market cap (USD): 1287879295.6000001
Debt to equity: 0.3536952990236305
Current ratio: 1.2303376268540203
Quick ratio: 1.154574876398647
Interest coverage ratio: -26.443995381062354
COGS to revenue (%): 48.38970563037593
R&D to revenue (%): 14.131798087796854
SG&A to revenue (%): 68.86946986052568
Free cash flow (dilution-adjusted): -39421000
Buyback yield (%): 0
Retained earnings: -387802000
Inventory turnover: 7.577868412579156
Receivables turnover: 3.1004037399065023
Capitalized R&D asset: 44403910
ROCI (R&D-adjusted, %): -21.266674256214362
Rosenberg metric: 0.6755949842190565
FCF margin (%): -27.01826530961927
Revenue growth (%): 40.47561738795552
Rule of 40 score: 13.457352078336253
Financial ratios for EVLV — quarterly report dated 2025-12-31
Total revenue: 38504000
Gross profit: 18628000
Operating income: -24637000
Net income: 10882000
Capital expenditures: 2258000
Operating cash flow: 15571000
Depreciation & amortization: 6481000
Net tangible assets: 119422000
Owner earnings: 15105000
Return on net tangible assets (%): 12.648423238599252
Buffett classification: The Gruesome
Stock price: 7.16
P/E ratio: 29.58737584083808
Shares outstanding: 179871410
Book value: 119422000
P/B ratio: 10.784271705380919
Market cap (USD): 1287879295.6000001
Debt to equity: 0.3536952990236305
Current ratio: 1.2303376268540203
Quick ratio: 1.154574876398647
Effective tax rate (%): 0
Interest coverage ratio: -24.201375245579566
COGS to revenue (%): 51.62061084562642
R&D to revenue (%): 14.055682526490754
SG&A to revenue (%): 98.30926656970705
Free cash flow (dilution-adjusted): 6717000
Buyback yield (%): 0
Retained earnings: -387802000
Inventory turnover: 2.1333047118171087
Receivables turnover: 0.8181895452613684
Capitalized R&D asset: 10732570
ROCI (R&D-adjusted, %): -12.737626898165647
Rosenberg metric: -0.4775320970042796
FCF margin (%): 17.444940785372946
Revenue growth (%): -10.142357059509918
Rule of 40 score: 7.302583725863029
Financial ratios for FGH.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.08270676691729323
Shares outstanding: 2858078614
Market cap (USD): 236382441.7593985
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FGH.AX — annual report dated 2022-06-30
Operating income: -4955654.482758621
Net income: -4160181.379310345
Capital expenditures: 2749292.4137931033
Depreciation & amortization: 483573.1034482759
Net tangible assets: 4612906.206896552
Owner earnings: -6425900.689655172
Return on net tangible assets (%): -139.30265219891297
Buffett classification: The Gruesome
Stock price: 0.055172413793103454
Shares outstanding: 2858078614
Book value: 4612906.206896551
P/B ratio: 34.18389381277179
Market cap (USD): 157687095.94482762
Debt to equity: 0.6928962727364334
Current ratio: 0.8374701477304282
Quick ratio: 0.8168569590630185
Interest coverage ratio: -11.07731475629195
Free cash flow (dilution-adjusted): -5610702.068965517
Buyback yield (%): 0.20993124438948688
Retained earnings: -11990696.551724138
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -79.93507700553283
Rule of 40 score: 0
Financial ratios for FGH.AX — annual report dated 2023-06-30
Total revenue: 10458.278145695363
Gross profit: 10458.278145695363
Operating income: -3113181.4569536424
Net income: -5434958.940397351
Capital expenditures: 1574252.3178807946
Depreciation & amortization: 425843.7086092715
Net tangible assets: 5296693.377483443
Owner earnings: -6583367.549668874
Return on net tangible assets (%): -124.29202675116437
Buffett classification: The Gruesome
Stock price: 0.006622516556291391
Shares outstanding: 2858078614
Book value: 5296693.377483444
P/B ratio: 3.573488512825757
Market cap (USD): 18927672.940397352
Debt to equity: 0.20018874702160175
Current ratio: 2.3325245122656573
Quick ratio: 2.3088327278142784
Interest coverage ratio: -13.120681474369352
COGS to revenue (%): 0
SG&A to revenue (%): 16299.259118541033
Free cash flow (dilution-adjusted): -3964512.582781457
Buyback yield (%): 1.8979184034438878
Retained earnings: -16949203.973509934
Inventory turnover: 0
Receivables turnover: 0.029676400947119173
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -49.577956521743715
FCF margin (%): -37907.89007092199
Rule of 40 score: -37907.89007092199
Financial ratios for FGH.AX — annual report dated 2024-06-30
Operating income: -3060911.3333333335
Net income: -6433430
Capital expenditures: 348025.3333333333
Depreciation & amortization: 238876
Net tangible assets: 137565.33333333334
Owner earnings: -6542579.333333333
Return on net tangible assets (%): -4755.979704189039
Buffett classification: The Gruesome
Stock price: 0.006666666666666667
Shares outstanding: 2858078614
Book value: 1675805.9999999998
P/B ratio: 11.369966109840083
Market cap (USD): 19053857.42666667
Debt to equity: 0.5519501262874901
Current ratio: 3.310449844856355
Quick ratio: 3.306501929135929
Interest coverage ratio: -56.63459972862958
Free cash flow (dilution-adjusted): -3088538.6666666665
Buyback yield (%): 1.0110183764175493
Retained earnings: -24418605.333333332
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -121.43158270017287
Rule of 40 score: 0
Financial ratios for FLO.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.017702702702702702
Shares outstanding: 81436375
Market cap (USD): 1441643.935810811
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0